KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $88.3 million.

  • Neogenomics' Total Current Liabilities fell 7068.79% to $88.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $88.3 million, marking a year-over-year decrease of 7068.79%. This contributed to the annual value of $88.3 million for FY2025, which is 7068.79% down from last year.
  • Per Neogenomics' latest filing, its Total Current Liabilities stood at $88.3 million for Q4 2025, which was down 7068.79% from $97.9 million recorded in Q3 2025.
  • Neogenomics' Total Current Liabilities' 5-year high stood at $301.2 million during Q4 2024, with a 5-year trough of $67.8 million in Q1 2021.
  • In the last 5 years, Neogenomics' Total Current Liabilities had a median value of $92.8 million in 2021 and averaged $129.4 million.
  • Examining YoY changes over the last 5 years, Neogenomics' Total Current Liabilities showed a top increase of 26461.35% in 2025 and a maximum decrease of 7068.79% in 2025.
  • Over the past 5 years, Neogenomics' Total Current Liabilities (Quarter) stood at $87.2 million in 2021, then rose by 3.1% to $89.9 million in 2022, then increased by 7.09% to $96.3 million in 2023, then skyrocketed by 212.8% to $301.2 million in 2024, then plummeted by 70.69% to $88.3 million in 2025.
  • Its Total Current Liabilities was $88.3 million in Q4 2025, compared to $97.9 million in Q3 2025 and $100.1 million in Q2 2025.